Pharmaceutical

Filter

Current filters:

None

Popular Filters

6576 to 6600 of 6948 results

New EMA database gives access to declarations of interests of all experts

02-10-2011

Coinciding with the entry into force of new rules on how to handle conflicts of interests of scientific…

BiotechnologyEuropePharmaceuticalRegulation

Study finds propranolol promising treatment for improving language, social function in people with autism

02-10-2011

Most drug therapy interventions for people with autism have targeted psychiatric problems, including…

Cardio-vascularNeurologicalPharmaceuticalPropranololResearch

Life sciences industry failing to adequately manage talent, RSA research finds

02-10-2011

While 90% of life sciences executives identify talent management as a key priority, over three quarters…

BiotechnologyManagementPharmaceutical

AstraZeneca in patent settlement deal with Handa over Seroquel XR

30-09-2011

Anglo-Swedish drug major AstraZeneca (LSE: AN) yesterday revealed that it has entered into a settlement…

AstraZenecaGenericsHanda PharmaceuticalsNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm

30-09-2011

Danish central nervous system specialist Lundbeck (LUND: DC) and the UK’s Proximagen Group (AIM:…

LundbeckMergers & AcquisitionsNeurologicalPharmaceuticalProximagenResearch

Pfizer partners with USA’s NABP to warn about counterfeit Rx drugs

29-09-2011

Global drugs behemoth Pfizer (NYSE: PFE) and the USA’s National Association of Boards of Pharmacy…

Markets & MarketingNorth AmericaPfizerPharmaceutical

Astellas drops development of blood thinner darexaban

29-09-2011

Japanese drug major Astellas Pharma (TYO: 4503) says it has decided to discontinue the global development…

Astellas PharmaCardio-vasculardarexabanPharmaceuticalRegulationResearch

Takeda and Pronova file for triglyceride lowererTAK-085 approval in Japan

29-09-2011

Norway-based lipid therapies specialist Pronova BioPharma says that its partner, Takeda Pharmaceutical…

Asia-PacificCardio-vascularPharmaceuticalRegulationTakeda Pharmaceuticals

Novel disease-modifying therapies will drive MS market to $11.5 billion in 2015

29-09-2011

The launch of several premium-priced novel disease-modifying therapies, including four oral agents, will…

BiotechnologyGlobalMarkets & MarketingNeurologicalPharmaceutical

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix

29-09-2011

An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

Onyx Pharma files NDA for multiple myeloma drug carfilzomib

29-09-2011

California, USA-based Onyx Pharmaceuticals (Nasdaq: ONXX) says it has completed the New Drug Application…

carfilzomibNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia

29-09-2011

The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…

GlobalHealthcarePharmaceuticalVaccines

Executive appointments at Merck & Co, Actelion and Jazz Pharma

28-09-2011

US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective…

ActelionBiotechnologyJazz PharmaceuticalsManagementMerck & CoPharmaceutical

Canada’s national health spending crunch the result of public insurance programs, not drug costs

28-09-2011

Claims that prescription drug costs are at the root of Canada’s health spending crisis are unfounded…

HealthcareNorth AmericaPharmaceuticalPricing

MVA-B Spanish HIV vaccine shows 90% immune response in humans

28-09-2011

Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with…

Anti-viralsPharmaceuticalResearch

Off-label use of antipsychotics for some conditions not supported by evidence, says US govt agency

28-09-2011

There is little evidence to support the use of atypical antipsychotic drugs for some treatments other…

NeurologicalNorth AmericaPharmaceuticalRegulation

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million

28-09-2011

The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

GPhA joins in US drug shortages challenge, urging “unprecedented multi-stakeholder collaboration”

28-09-2011

With shortages of prescription drugs continuing in the USA, the country’s Generic Pharmaceutical…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

6576 to 6600 of 6948 results

Back to top